nalumed.comHealthcare / Medical DevicesFounded: 2014Funding to Date: $613.49MM
Nalu Medical, Inc. is a medical technology company specializing in developing innovative solutions for chronic pain management. The company focuses on neuromodulation therapies with medical devices to address various pain conditions.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/21/2023 | Series E | $115.06MM | $xx.xx | $382.56MM | Advent Life Sciences, Aperture Venture Partners, B Capital, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, Mvm Partners, Novo Holdings, Pura Vida | |
Price per Share
$xx.xx
Shares Outstanding
23,744,605
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3
Key Investors
Advent Life Sciences, Aperture Venture Partners, B Capital, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, Mvm Partners, Novo Holdings, Pura Vida
|
||||||
02/17/2022 | Series D-1 | $97.87MM | $xx.xx | $231.26MM | Advent Life Sciences, Aperture Venture Partners, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, Mvm Partners, Pura Vida | |
Price per Share
$xx.xx
Shares Outstanding
20,197,293
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Advent Life Sciences, Aperture Venture Partners, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, Mvm Partners, Pura Vida
|
||||||
02/17/2022 | Series D-2 | $6.68MM | $xx.xx | $231.26MM | Advent Life Sciences, Aperture Venture Partners, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, Mvm Partners, Pura Vida | |
Price per Share
$xx.xx
Shares Outstanding
1,531,927
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Advent Life Sciences, Aperture Venture Partners, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, Mvm Partners, Pura Vida
|
||||||
07/01/2020 | Series C | $65.15MM | $xx.xx | $154.59MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,565,410
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
05/15/2018 | Series B | $35.09MM | $xx.xx | $105.53MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,574,511
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/26/2015 | Series A-1 | $4.31MM | $xx.xx | $25.55MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
837,986
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/26/2015 | Series A-2 | $7.61MM | $xx.xx | $25.55MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,232,356
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|